The role of the dopamine transporter in cocaine abuse.
Level 5 - mechanism / opinion, no new human data
Narrative review of preclinical and animal mechanistic research without systematic methodology.
PubMed 15545021 · doi:10.1007/BF03033312
What was done
This narrative review summarizes literature examining the role of dopamine transporter inhibition in cocaine abuse, focusing on the neurochemical mechanisms governing acute behavioral responses and chronic behavioral sensitization in animal models.
What was found
The abstract reports no quantitative data. Qualitatively, dopamine transporter binding and uptake inhibition are established as the primary mediators of cocaine's acute behavioral effects. However, in chronic exposure models, selective dopamine uptake inhibitors produce sensitization, but the long-lasting sensitized response to cocaine challenge in cocaine-pretreated rats involves neurochemical pathways other than, or in addition to, dopamine.
Why it matters
It highlights that therapeutic strategies or models focusing exclusively on dopamine transporter inhibition may fail to account for the persistent neuroadaptations underlying chronic cocaine use.
Limits
The abstract contains no quantitative metrics, effect sizes, or sample sizes. The summarized findings rely on preclinical rodent models rather than human clinical data, and the review lacks a systematic methodology.